Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06120075
Title A Study of AB801 Monotherapy and Combination Therapy in Participants With Advanced Malignancies (ARC-27)
Acronym ARC-27
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Arcus Biosciences, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST